CdMT
|
Glutamine codons
|
---|
CAA
|
UAA
|
UAG
|
CAG
|
Total
|
---|
TpigMT-1
|
3
|
1
|
0
|
0
|
4
|
TpyrMT-1
|
0
|
0
|
0
|
0
|
0
|
TpyrMT-2
|
2
|
10
|
2
|
0
|
14
|
TtheMTT1
|
2
|
4
|
1
|
0
|
7
|
TtheMTT3
|
2
|
5
|
1
|
1
|
9
|
TtheMTT5
|
2
|
1
|
0
|
0
|
3
|
TrosMTT1
|
2
|
2
|
0
|
0
|
4
|
TtroMTT1
|
3
|
1
|
0
|
0
|
4
|
TmobMT1
|
4
|
1
|
0
|
0
|
5
|
TvorMT1
|
4
|
0
|
0
|
0
|
4
|
ThegMT1
|
2
|
2
|
0
|
0
|
4
|
ThegMT2
|
2
|
4
|
2
|
0
|
8
|
ThegMT3
|
1
|
3
|
0
|
1
|
5
|
ThegMT4
|
1
|
10
|
5
|
1
|
17
|
TborMTT1
|
2
|
4
|
0
|
0
|
6
|
TborMTT2
|
3
|
3
|
1
|
0
|
7
|
TelliMTT1
|
1
|
6
|
2
|
0
|
9
|
TelliMTT2
|
3
|
5
|
3
|
0
|
11
|
TmalaMTT1
|
1
|
5
|
1
|
0
|
7
|
TmalaMTT2
|
3
|
3
|
1
|
0
|
7
|
TmalaMTT3
|
2
|
5
|
0
|
0
|
7
|
TmalaMTT4
|
0
|
5
|
0
|
0
|
5
|
TpatMTT1
|
2
|
4
|
1
|
0
|
7
|
TpatMTT2
|
2
|
4
|
5
|
0
|
11
|
TamerMTT1
|
1
|
4
|
1
|
0
|
6
|
TamerMTT2
|
2
|
4
|
1
|
0
|
7
|
Total (%)
a
|
52 (29.21 %)
|
96 (53.93 %)
|
27 (15.17 %)
|
3 (1.69 %)
|
178 (100 %)
|
CuMT
| |
TpigMT-2
|
6
|
0
|
0
|
0
|
6
|
TtheMTT2
|
4
|
0
|
0
|
0
|
4
|
TtheMTT4
|
4
|
0
|
0
|
0
|
4
|
TrosMTT2
|
5
|
0
|
0
|
0
|
5
|
TtroMT1
|
5
|
0
|
0
|
1
|
6
|
TtroMT2
|
2
|
0
|
1
|
1
|
4
|
Sp1.7-MT1
|
3
|
2
|
2
|
0
|
7
|
TelliMTT6
|
5
|
1
|
0
|
0
|
6
|
TelliMTT8
|
3
|
2
|
0
|
0
|
5
|
TmalaMTT5
|
3
|
1
|
0
|
0
|
4
|
TborMTT3
|
4
|
7
|
2
|
0
|
13
|
TborMTT4
|
2
|
0
|
0
|
0
|
2
|
TborMTT6
|
4
|
7
|
2
|
0
|
13
|
TborMTT7
|
5
|
2
|
1
|
0
|
8
|
TborMTT8
|
5
|
0
|
0
|
0
|
5
|
TamerMTT3
|
4
|
0
|
0
|
0
|
4
|
ImMTT2
|
1
|
9
|
0
|
0
|
10
|
Total (%)
a
|
65 (61.32 %)
|
31 (29.24 %)
|
8 (7.55 %)
|
2 (1.89 %)
|
106 (100 %)
|
- New MTs reported in this study are in bold text.a Total glutamine residues using a type of codon and percentage